Kim Tae Kyun, Kim Gwang Ha, Park Do Youn, Lee Bong Eun, Jeon Tae Yong, Kim Dae Hwan, Jo Hong Jae, Song Geun Am
Department of Internal Medicine, Pusan National University School of Medicine, 179, Gudeok-ro, Seo-gu, Busan, 602-739, Korea.
Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, 179, Gudeok-ro, Seo-Gu, Busan, 602-739, Korea.
Surg Endosc. 2015 Oct;29(10):2891-8. doi: 10.1007/s00464-014-4016-6. Epub 2014 Dec 6.
With the widespread use of endoscopic submucosal dissection (ESD) in patients with early gastric cancer (EGC), the number of cases with incomplete resection due to positive lateral resection margins (LM+) is increasing. Local recurrence, which occurs frequently in LM+ cases, is an important issue. This study aimed to clarify the clinicopathological factors related to tumor recurrence in LM+ cases after ESD for EGC.
From January 2005 to December 2012, a total of 1,083 patients with EGC underwent ESD at our hospital. Of these, cases with a pathological diagnosis of LM+ were included in this study. Patients with positive vertical resection margins, those who underwent surgical resection immediately or were followed up for less than 6 months after ESD, were excluded.
A total of 55 LM+ cases after ESD for EGC were enrolled. Incorrect delineation of a lesion that extended pathologically beyond the ESD marking dots was the main cause of LM+. Local recurrence was found in 20 (36.4 %) patients (median follow-up period, 23 months). Local recurrence rates related to LM+ length were as follows: 7/29 (24.1 %) in 2 mm, 6/16 (37.5 %) in 4 mm, 1/3 (33.3 %) in 6 mm, 4/5 (80 %) in 8 mm, and 2/2 (100 %) in ≥ 10 mm. In multivariate analysis, tumor size > 2 cm (OR 4.48, 95 % CI 1.18-16.99, p = 0.027), and LM+ length > 6 mm (OR 7.65, 95 % CI 1.15-50.70, p = 0.035) were independent risk factors for tumor recurrence.
To decrease the risk of LM+, it is highly important to accurately delineate the lateral margins during ESD; when the final histopathological result is LM+, cases with LM+ length >6 mm or tumor size > 2 cm should be considered for additional surgical resection or re-ESD because of a high risk of tumor recurrence.
随着内镜黏膜下剥离术(ESD)在早期胃癌(EGC)患者中的广泛应用,因侧切缘阳性(LM+)导致切除不完全的病例数量正在增加。LM+病例中频繁发生的局部复发是一个重要问题。本研究旨在阐明EGC患者ESD术后LM+病例中与肿瘤复发相关的临床病理因素。
2005年1月至2012年12月,共有1083例EGC患者在我院接受了ESD。其中,病理诊断为LM+的病例纳入本研究。垂直切缘阳性的患者、ESD后立即接受手术切除或随访时间少于6个月的患者被排除。
共纳入55例EGC患者ESD术后LM+病例。病理上超出ESD标记点的病变划定错误是LM+的主要原因。20例(36.4%)患者出现局部复发(中位随访期为23个月)。与LM+长度相关的局部复发率如下:2mm时为7/29(24.1%),4mm时为6/16(37.5%),6mm时为1/3(33.3%),8mm时为4/5(80%),≥10mm时为2/2(100%)。多因素分析显示,肿瘤大小>2cm(OR 4.48,95%CI 1.18 - 16.99,p = 0.027)和LM+长度>6mm(OR 7.65,95%CI 1.15 - 50.70,p = 0.035)是肿瘤复发的独立危险因素。
为降低LM+的风险,在ESD期间准确划定侧切缘非常重要;当最终组织病理学结果为LM+时,由于肿瘤复发风险高,LM+长度>6mm或肿瘤大小>2cm的病例应考虑额外手术切除或再次ESD。